Summit soars after $2bn investment from AstraZeneca for cancer therapies

Summit to test dual cancer therapies in major pharma alliance

Summit soars after $2bn investment from AstraZeneca for cancer therapies
Summit to test dual cancer therapies in major pharma alliance